Alpha Tau Medical, a cancer biotech company, announced on Friday that it has named Prof Yona Keisari as its chief scientific officer.

Prof Keisari will lead the company's research activities towards the aim of curing cancer.

Prof Keisari has been a member of the Department of Clinical Microbiology and Immunology, at the Faculty of Medicine at Tel Aviv University in Israel, since 1979. In 2016, he co-founded Alpha Tau Medical along with TAU physics professor Itzhak Kelson, and the company's CEO Uzi Sofer. Since then, he has served as chief biomedical officer, involved in promoting the company's clinical activities and responsible for preclinical research activities. Prof Keisari co-authored 90 peer-reviewed scientific papers and is an editorial board member of 5 journals. He was a founder and past president of the Israeli Society for Cancer Research and a member of the executive committee of the European Association for Cancer Research. He now serves as the treasurer of the International Cancer Microenvironment Society.